{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/358260327"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Lemtrada was a centerpiece of its $20-billion purchase of the biotech in 2011, and contingent payments valued at $3.8 billion, for such things as regulatory approval and the drug hitting specific sales targets, were tacked onto the takeover deal." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "mmm-online.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/362630504"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/358260327"] } } }
